O	O	0	14	Autoregulation	Autoregulation	B-NP	NN	O	0	ROOT	O
O	O	15	17	of	of	B-PP	IN	O	1	NMOD	O
O	O	18	21	the	the	B-NP	DT	O	8	NMOD	O
O	O	22	24	NF	NF	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	24	25	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
O	O	25	30	kappa	kappa	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	31	32	B	B	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	33	47	transactivator	transactivator	I-NP	NN	I-protein	2	PMOD	I-protein
T1	B-Protein	48	52	RelA	RelA	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	53	54	(	(	O	(	O	12	DEP	O
T2	B-Protein	54	57	p65	p65	B-NP	NN	B-protein	12	DEP	B-protein
O	O	57	58	)	)	O	)	O	9	NMOD	O
O	O	59	61	by	by	B-PP	IN	O	1	NMOD	O
O	O	62	70	multiple	multiple	B-NP	JJ	O	16	NMOD	O
O	O	71	82	cytoplasmic	cytoplasmic	I-NP	JJ	B-protein	16	NMOD	B-protein
O	O	83	93	inhibitors	inhibitor	I-NP	NNS	I-protein	13	PMOD	I-protein
O	O	94	104	containing	contain	B-VP	VBG	O	16	NMOD	O
T36	B-Entity	105	112	ankyrin	ankyrin	B-NP	NN	B-protein	19	NMOD	B-protein
T36	I-Entity	113	119	motifs	motif	I-NP	NNS	I-protein	17	OBJ	I-protein
O	O	119	120	.	.	O	.	O	1	P	O

T3	B-Protein	122	126	RelA	RelA	B-NP	NN	B-protein	5	SUB	B-protein
O	O	127	128	(	(	O	(	O	4	DEP	O
T4	B-Protein	128	131	p65	p65	B-NP	NN	B-protein	4	DEP	B-protein
O	O	131	132	)	)	O	)	O	1	NMOD	O
O	O	133	142	functions	function	B-VP	VBZ	O	0	ROOT	O
O	O	143	145	as	as	B-PP	IN	O	5	VMOD	O
O	O	146	149	the	the	B-NP	DT	O	10	NMOD	O
O	O	150	158	critical	critical	I-NP	JJ	O	10	NMOD	O
O	O	159	174	transactivating	transactivate	I-NP	VBG	O	10	NMOD	O
O	O	175	184	component	component	I-NP	NN	O	6	PMOD	O
O	O	185	187	of	of	B-PP	IN	O	10	NMOD	O
O	O	188	191	the	the	B-NP	DT	O	21	NMOD	O
O	O	192	205	heterodimeric	heterodimeric	I-NP	JJ	B-protein	14	NMOD	B-protein
T5	B-Protein	206	209	p50	p50	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	209	210	-	-	O	HYPH	O	21	NMOD	O
T6	B-Protein	210	213	p65	p65	B-NP	NN	B-protein	21	NMOD	B-protein
T37	B-Entity	214	216	NF	NF	I-NP	NN	I-protein	21	NMOD	I-protein
T37	I-Entity	216	217	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
T37	I-Entity	217	222	kappa	kappa	I-NP	NN	I-protein	21	NMOD	I-protein
T37	I-Entity	223	224	B	B	I-NP	NN	I-protein	21	NMOD	I-protein
T37	I-Entity	225	232	complex	complex	I-NP	NN	I-protein	11	PMOD	I-protein
O	O	233	236	and	and	O	CC	O	5	VMOD	O
O	O	237	245	contains	contain	B-VP	VBZ	O	5	VMOD	O
O	O	246	247	a	a	B-NP	DT	O	29	NMOD	O
T38	B-Entity	248	252	high	high	I-NP	JJ	B-DNA	29	NMOD	B-DNA
T38	I-Entity	252	253	-	-	I-NP	HYPH	I-DNA	29	P	I-DNA
T38	I-Entity	253	261	affinity	affinity	I-NP	NN	I-DNA	29	NMOD	I-DNA
T38	I-Entity	262	269	binding	binding	I-NP	NN	I-DNA	29	NMOD	I-DNA
T38	I-Entity	270	274	site	site	I-NP	NN	I-DNA	23	OBJ	I-DNA
O	O	275	278	for	for	B-PP	IN	O	23	VMOD	O
O	O	279	282	its	its	B-NP	PRP$	O	33	NMOD	O
O	O	283	294	cytoplasmic	cytoplasmic	I-NP	JJ	B-protein	33	NMOD	B-protein
O	O	295	304	inhibitor	inhibitor	I-NP	NN	I-protein	38	NMOD	I-protein
O	O	304	305	,	,	O	,	O	38	P	O
T7	B-Protein	306	307	I	I	B-NP	NN	B-protein	38	NMOD	B-protein
T7	I-Protein	308	313	kappa	kappa	I-NP	NN	I-protein	38	NMOD	I-protein
T7	I-Protein	314	315	B	B	I-NP	NN	I-protein	38	NMOD	I-protein
T7	I-Protein	316	321	alpha	alpha	I-NP	NN	I-protein	30	PMOD	I-protein
O	O	321	322	.	.	O	.	O	5	P	O

O	O	323	328	After	After	B-PP	IN	O	9	VMOD	O
O	O	329	337	cellular	cellular	B-NP	JJ	O	3	NMOD	O
O	O	338	348	activation	activation	I-NP	NN	O	1	PMOD	O
O	O	348	349	,	,	O	,	O	9	P	O
T8	B-Protein	350	351	I	I	B-NP	NN	B-protein	8	NMOD	B-protein
T8	I-Protein	352	357	kappa	kappa	I-NP	NN	I-protein	8	NMOD	I-protein
T8	I-Protein	358	359	B	B	I-NP	NN	I-protein	8	NMOD	I-protein
T8	I-Protein	360	365	alpha	alpha	I-NP	NN	I-protein	9	SUB	I-protein
O	O	366	368	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	369	376	rapidly	rapidly	I-VP	RB	O	11	VMOD	O
O	O	377	385	degraded	degrade	I-VP	VBN	O	9	VC	O
O	O	386	388	in	in	B-PP	IN	O	11	VMOD	O
O	O	389	396	concert	concert	B-NP	NN	O	12	PMOD	O
O	O	397	401	with	with	B-PP	IN	O	11	VMOD	O
O	O	402	405	the	the	B-NP	DT	O	18	NMOD	O
O	O	406	413	induced	induce	I-NP	VBN	O	18	NMOD	O
O	O	414	421	nuclear	nuclear	I-NP	JJ	O	18	NMOD	O
O	O	422	435	translocation	translocation	I-NP	NN	O	14	PMOD	O
O	O	436	438	of	of	B-PP	IN	O	18	NMOD	O
T39	B-Entity	439	441	NF	NF	B-NP	NN	B-protein	23	NMOD	B-protein
T39	I-Entity	441	442	-	-	B-NP	HYPH	I-protein	23	NMOD	I-protein
T39	I-Entity	442	447	kappa	kappa	I-NP	NN	I-protein	23	NMOD	I-protein
T39	I-Entity	448	449	B	B	I-NP	NN	I-protein	19	PMOD	I-protein
O	O	449	450	.	.	O	.	O	9	P	O

O	O	451	454	The	The	B-NP	DT	O	3	NMOD	O
O	O	455	462	present	present	I-NP	JJ	O	3	NMOD	O
O	O	463	468	study	study	I-NP	NN	O	4	SUB	O
O	O	469	481	demonstrates	demonstrate	B-VP	VBZ	O	0	ROOT	O
O	O	482	486	that	that	B-SBAR	IN	O	4	VMOD	O
T9	B-Protein	487	492	tumor	tumor	B-NP	NN	B-protein	10	SUB	B-protein
T9	I-Protein	493	501	necrosis	necrosis	I-NP	NN	I-protein	9	NMOD	I-protein
T9	I-Protein	502	508	factor	factor	I-NP	NN	I-protein	9	NMOD	I-protein
T9	I-Protein	509	514	alpha	alpha	B-NP	SYM	I-protein	6	NMOD	I-protein
O	O	514	515	-	-	B-VP	HYPH	O	22	SUB	O
O	O	515	522	induced	induce	B-NP	VBN	O	12	NMOD	O
O	O	523	534	degradation	degradation	I-NP	NN	O	10	OBJ	O
O	O	535	537	of	of	B-PP	IN	O	12	NMOD	O
T10	B-Protein	538	539	I	I	B-NP	NN	B-protein	17	NMOD	B-protein
T10	I-Protein	540	545	kappa	kappa	I-NP	NN	I-protein	17	NMOD	I-protein
T10	I-Protein	546	547	B	B	I-NP	NN	I-protein	17	NMOD	I-protein
T10	I-Protein	548	553	alpha	alpha	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	554	556	in	in	B-PP	IN	O	12	NMOD	O
O	O	557	562	human	human	B-NP	JJ	B-cell_type	21	NMOD	B-cell_type
O	O	563	564	T	T	I-NP	NN	I-cell_type	21	NMOD	I-cell_type
O	O	565	570	cells	cell	I-NP	NNS	I-cell_type	18	PMOD	I-cell_type
O	O	571	573	is	be	B-VP	VBZ	O	5	SBAR	O
O	O	574	582	preceded	precede	I-VP	VBN	O	22	VC	O
O	O	583	585	by	by	B-PP	IN	O	23	VMOD	O
O	O	586	589	its	its	B-NP	PRP$	O	27	NMOD	O
O	O	590	595	rapid	rapid	I-NP	JJ	O	27	NMOD	O
O	O	596	611	phosphorylation	phosphorylation	I-NP	NN	O	24	PMOD	O
O	O	612	614	in	in	B-ADVP	FW	O	23	VMOD	O
O	O	615	619	vivo	vivo	I-ADVP	FW	O	28	AMOD	O
O	O	619	620	.	.	O	.	O	4	P	O

O	O	621	628	However	However	B-ADVP	RB	O	10	VMOD	O
O	O	628	629	,	,	O	,	O	10	P	O
O	O	630	635	these	these	B-NP	DT	O	4	NMOD	O
O	O	636	643	effects	effect	I-NP	NNS	O	10	SUB	O
O	O	644	646	on	on	B-PP	IN	O	4	NMOD	O
T11	B-Protein	647	648	I	I	B-NP	NN	B-protein	9	NMOD	B-protein
T11	I-Protein	649	654	kappa	kappa	I-NP	NN	I-protein	9	NMOD	I-protein
T11	I-Protein	655	656	B	B	I-NP	NN	I-protein	9	NMOD	I-protein
T11	I-Protein	657	662	alpha	alpha	I-NP	NN	I-protein	5	PMOD	I-protein
O	O	663	669	result	result	B-VP	VBP	O	0	ROOT	O
O	O	670	672	in	in	B-PP	IN	O	10	VMOD	O
O	O	673	680	nuclear	nuclear	B-NP	JJ	O	13	NMOD	O
O	O	681	693	mobilization	mobilization	I-NP	NN	O	11	PMOD	O
O	O	694	696	of	of	B-PP	IN	O	13	NMOD	O
O	O	697	701	only	only	B-NP	RB	O	17	NMOD	O
O	O	702	703	a	a	I-NP	DT	O	17	NMOD	O
O	O	704	712	fraction	fraction	I-NP	NN	O	14	PMOD	O
O	O	713	715	of	of	B-PP	IN	O	17	NMOD	O
O	O	716	719	the	the	B-NP	DT	O	22	NMOD	O
O	O	720	726	entire	entire	I-NP	JJ	O	22	NMOD	O
O	O	727	738	cytoplasmic	cytoplasmic	I-NP	JJ	O	22	NMOD	O
O	O	739	743	pool	pool	I-NP	NN	O	18	PMOD	O
O	O	744	746	of	of	B-PP	IN	O	22	NMOD	O
T12	B-Protein	747	751	RelA	RelA	B-NP	NN	B-protein	23	PMOD	B-protein
O	O	751	752	.	.	O	.	O	10	P	O

O	O	753	763	Subsequent	Subsequent	B-NP	JJ	O	2	NMOD	O
O	O	764	771	studies	study	I-NP	NNS	O	3	SUB	O
O	O	772	776	have	have	B-VP	VBP	O	0	ROOT	O
O	O	777	785	revealed	reveal	I-VP	VBN	O	3	VC	O
O	O	786	790	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	791	792	(	(	B-LST	(	O	7	DEP	O
O	O	792	793	i	i	I-LST	LS	O	11	VMOD	O
O	O	793	794	)	)	O	)	O	7	DEP	O
O	O	795	806	cytoplasmic	cytoplasmic	B-NP	JJ	B-protein	10	NMOD	B-protein
T13	B-Protein	807	811	RelA	RelA	I-NP	NN	I-protein	11	SUB	I-protein
O	O	812	814	is	be	B-VP	VBZ	O	142	VMOD	O
O	O	815	821	stably	stably	I-VP	RB	O	13	VMOD	O
O	O	822	832	associated	associate	I-VP	VBN	O	11	VC	O
O	O	833	836	not	not	B-CONJP	RB	O	13	VMOD	O
O	O	837	841	only	only	I-CONJP	RB	O	14	DEP	O
O	O	842	846	with	with	B-PP	IN	O	14	PMOD	O
T14	B-Protein	847	848	I	I	B-NP	NN	B-protein	20	NMOD	B-protein
T14	I-Protein	849	854	kappa	kappa	I-NP	NN	I-protein	20	NMOD	I-protein
T14	I-Protein	855	856	B	B	I-NP	NN	I-protein	20	NMOD	I-protein
T14	I-Protein	857	862	alpha	alpha	I-NP	NN	I-protein	16	PMOD	I-protein
O	O	863	866	but	but	B-CONJP	CC	O	14	PMOD	O
O	O	867	871	also	also	I-CONJP	RB	O	21	DEP	O
O	O	872	876	with	with	B-PP	IN	O	14	PMOD	O
O	O	877	882	other	other	B-NP	JJ	O	29	NMOD	O
O	O	883	890	ankyrin	ankyrin	I-NP	NN	B-protein	26	NMOD	B-protein
O	O	891	896	motif	motif	I-NP	NN	I-protein	29	NMOD	I-protein
O	O	896	897	-	-	B-NP	HYPH	I-protein	29	NMOD	I-protein
O	O	897	901	rich	rich	I-NP	JJ	I-protein	29	NMOD	I-protein
O	O	902	910	proteins	protein	I-NP	NNS	I-protein	23	PMOD	I-protein
O	O	911	920	including	include	B-PP	VBG	O	29	NMOD	O
O	O	921	924	the	the	B-NP	DT	O	32	NMOD	O
O	O	925	933	products	product	I-NP	NNS	O	30	PMOD	O
O	O	934	936	of	of	B-PP	IN	O	32	NMOD	O
O	O	937	940	the	the	B-NP	DT	O	50	NMOD	O
T15	B-Protein	941	943	NF	NF	I-NP	NN	O	50	NMOD	O
T15	I-Protein	943	944	-	-	O	HYPH	O	50	P	O
T15	I-Protein	944	949	kappa	kappa	B-NP	NN	B-DNA	38	NMOD	B-DNA
T15	I-Protein	950	952	B2	B2	I-NP	NN	I-DNA	50	NMOD	I-DNA
O	O	953	954	(	(	O	(	O	41	DEP	O
T16	B-Protein	954	958	p100	p100	B-NP	NN	B-protein	41	DEP	B-protein
O	O	958	959	)	)	O	)	O	38	NMOD	O
O	O	960	963	and	and	O	CC	O	50	NMOD	O
T17	B-Protein	964	966	NF	NF	B-NP	NN	O	50	NMOD	O
T17	I-Protein	966	967	-	-	O	HYPH	O	50	P	O
T17	I-Protein	967	972	kappa	kappa	B-NP	NN	B-DNA	50	NMOD	B-DNA
T17	I-Protein	973	975	B1	B1	I-NP	NN	I-DNA	50	NMOD	I-DNA
O	O	976	977	(	(	O	(	I-DNA	49	DEP	I-DNA
T18	B-Protein	977	981	p105	p105	B-NP	NN	I-DNA	49	DEP	I-DNA
O	O	981	982	)	)	O	)	I-DNA	46	NMOD	I-DNA
O	O	983	988	genes	gene	B-NP	NNS	I-DNA	33	PMOD	I-DNA
O	O	988	989	;	;	O	:	O	142	P	O
O	O	990	991	(	(	B-LST	(	O	53	DEP	O
O	O	991	993	ii	ii	I-LST	LS	O	70	VMOD	O
O	O	993	994	)	)	O	)	O	53	DEP	O
O	O	995	997	in	in	B-PP	IN	O	70	VMOD	O
O	O	998	1006	contrast	contrast	B-NP	NN	O	55	PMOD	O
O	O	1007	1009	to	to	B-PP	TO	O	55	PMOD	O
T19,T40	B-Protein,B-Entity	1010	1014	RelA	RelA	B-NP	NN	B-protein	69	NMOD	B-protein
T40	I-Entity	1014	1015	-	-	I-NP	HYPH	O	69	NMOD	O
T20,T40	B-Protein,I-Entity	1015	1016	I	I	I-NP	NN	B-protein	63	NMOD	B-protein
T20,T40	I-Protein,I-Entity	1017	1022	kappa	kappa	I-NP	NN	I-protein	63	NMOD	I-protein
T20,T40	I-Protein,I-Entity	1023	1024	B	B	I-NP	NN	I-protein	63	NMOD	I-protein
T20,T40	I-Protein,I-Entity	1025	1030	alpha	alpha	I-NP	NN	I-protein	69	NMOD	I-protein
O	O	1030	1031	,	,	O	,	O	69	P	O
T21	B-Protein	1032	1036	RelA	RelA	B-NP	NN	B-protein	69	NMOD	B-protein
O	O	1036	1037	-	-	B-NP	HYPH	O	69	NMOD	O
T22	B-Protein	1037	1041	p100	p100	I-NP	NN	B-protein	69	NMOD	B-protein
T41	B-Entity	1042	1053	cytoplasmic	cytoplasmic	I-NP	JJ	I-protein	69	NMOD	I-protein
T41	I-Entity	1054	1063	complexes	complex	I-NP	NNS	I-protein	55	PMOD	I-protein
O	O	1064	1067	are	be	B-VP	VBP	O	142	VMOD	O
O	O	1068	1071	not	not	I-VP	RB	O	70	VMOD	O
O	O	1072	1083	dissociated	dissociate	I-VP	VBN	O	70	VC	O
O	O	1084	1093	following	follow	B-PP	VBG	O	72	VMOD	O
T23	B-Protein	1094	1099	tumor	tumor	B-NP	NN	B-protein	78	NMOD	B-protein
T23	I-Protein	1100	1108	necrosis	necrosis	I-NP	NN	I-protein	78	NMOD	I-protein
T23	I-Protein	1109	1115	factor	factor	I-NP	NN	I-protein	78	NMOD	I-protein
T23	I-Protein	1116	1121	alpha	alpha	I-NP	NN	I-protein	78	NMOD	I-protein
O	O	1122	1132	activation	activation	I-NP	NN	O	73	PMOD	O
O	O	1132	1133	;	;	O	:	O	142	P	O
O	O	1134	1135	(	(	B-LST	(	O	81	DEP	O
O	O	1135	1138	iii	iii	I-LST	LS	O	84	VMOD	O
O	O	1138	1139	)	)	O	)	O	81	DEP	O
T24	B-Protein	1140	1144	p100	p100	B-NP	NN	B-protein	84	SUB	B-protein
O	O	1145	1154	functions	function	B-VP	VBZ	O	142	VMOD	O
O	O	1155	1157	as	as	B-PP	IN	O	84	VMOD	O
O	O	1158	1159	a	a	B-NP	DT	O	88	NMOD	O
O	O	1160	1166	potent	potent	I-NP	JJ	O	88	NMOD	O
O	O	1167	1176	inhibitor	inhibitor	I-NP	NN	O	93	NMOD	O
O	O	1177	1179	of	of	B-PP	IN	O	88	NMOD	O
T25	B-Protein	1180	1184	RelA	RelA	B-NP	NN	B-protein	89	PMOD	B-protein
O	O	1184	1185	-	-	O	HYPH	O	88	P	O
O	O	1185	1193	mediated	mediate	B-NP	VBN	O	93	NMOD	O
O	O	1194	1207	transcription	transcription	I-NP	NN	O	85	PMOD	O
O	O	1208	1210	in	in	B-ADVP	FW	O	84	VMOD	O
O	O	1211	1215	vivo	vivo	I-ADVP	FW	O	94	AMOD	O
O	O	1215	1216	;	;	O	:	O	142	P	O
O	O	1217	1218	(	(	B-LST	(	O	98	DEP	O
O	O	1218	1220	iv	iv	I-LST	LS	O	106	VMOD	O
O	O	1220	1221	)	)	O	)	O	98	DEP	O
O	O	1222	1225	the	the	B-NP	DT	O	101	NMOD	O
O	O	1226	1237	interaction	interaction	I-NP	NN	O	106	SUB	O
O	O	1238	1240	of	of	B-PP	IN	O	101	NMOD	O
T26	B-Protein	1241	1245	RelA	RelA	B-NP	NN	B-protein	105	NMOD	B-protein
O	O	1246	1249	and	and	I-NP	CC	O	105	NMOD	O
T27	B-Protein	1250	1254	p100	p100	I-NP	NN	B-protein	102	PMOD	B-protein
O	O	1255	1263	involves	involve	B-VP	VBZ	O	142	VMOD	O
O	O	1264	1267	the	the	B-NP	DT	O	111	NMOD	O
T42	B-Entity	1268	1277	conserved	conserve	I-NP	VBN	B-protein	111	NMOD	B-protein
T42	I-Entity	1278	1281	Rel	Rel	I-NP	NN	I-protein	111	NMOD	I-protein
T42	I-Entity	1282	1290	homology	homology	I-NP	NN	I-protein	111	NMOD	I-protein
T42	I-Entity	1291	1297	domain	domain	I-NP	NN	I-protein	120	NMOD	I-protein
O	O	1298	1300	of	of	B-PP	IN	O	111	NMOD	O
O	O	1301	1305	both	both	B-NP	DT	O	114	NMOD	O
O	O	1306	1314	proteins	protein	B-NP	NNS	O	112	PMOD	O
O	O	1315	1318	but	but	B-NP	CC	O	120	NMOD	O
O	O	1319	1322	not	not	I-NP	RB	O	115	DEP	O
O	O	1323	1326	the	the	B-NP	DT	O	120	NMOD	O
T43	B-Entity	1327	1334	nuclear	nuclear	I-NP	JJ	B-protein	120	NMOD	B-protein
T43	I-Entity	1335	1347	localization	localization	I-NP	NN	I-protein	120	NMOD	I-protein
T43	I-Entity	1348	1354	signal	signal	I-NP	NN	I-protein	106	OBJ	I-protein
O	O	1355	1357	of	of	B-PP	IN	O	120	NMOD	O
T28	B-Protein	1358	1362	RelA	RelA	B-NP	NN	B-protein	121	PMOD	B-protein
O	O	1362	1363	,	,	O	,	O	120	P	O
O	O	1364	1369	which	which	B-NP	WDT	O	120	NMOD	O
O	O	1370	1372	is	be	B-VP	VBZ	O	124	SBAR	O
O	O	1373	1381	required	require	I-VP	VBN	O	125	VC	O
O	O	1382	1385	for	for	B-PP	IN	O	126	VMOD	O
T29	B-Protein	1386	1387	I	I	B-NP	NN	B-protein	132	NMOD	B-protein
T29	I-Protein	1388	1393	kappa	kappa	I-NP	NN	I-protein	132	NMOD	I-protein
T29	I-Protein	1394	1395	B	B	I-NP	NN	I-protein	132	NMOD	I-protein
T29	I-Protein	1396	1401	alpha	alpha	I-NP	NN	I-protein	132	NMOD	I-protein
O	O	1402	1409	binding	binding	I-NP	NN	O	127	PMOD	O
O	O	1409	1410	;	;	O	:	O	142	P	O
O	O	1411	1412	(	(	B-LST	(	O	135	DEP	O
O	O	1412	1413	v	v	I-LST	LS	O	142	VMOD	O
O	O	1413	1414	)	)	O	)	O	135	DEP	O
T30	B-Protein	1415	1419	p100	p100	B-NP	NN	B-protein	138	NMOD	B-protein
O	O	1420	1430	inhibition	inhibition	I-NP	NN	O	142	SUB	O
O	O	1431	1433	of	of	B-PP	IN	O	138	NMOD	O
T31	B-Protein	1434	1438	RelA	RelA	B-NP	NN	B-protein	141	NMOD	B-protein
O	O	1439	1447	function	function	I-NP	NN	O	139	PMOD	O
O	O	1448	1456	requires	require	B-VP	VBZ	O	5	SBAR	O
O	O	1457	1460	the	the	B-NP	DT	O	149	NMOD	O
T44	B-Entity	1461	1462	C	C	I-NP	NN	B-protein	149	NMOD	B-protein
T44	I-Entity	1462	1463	-	-	B-NP	HYPH	I-protein	149	NMOD	I-protein
T44	I-Entity	1463	1471	terminal	terminal	I-NP	JJ	I-protein	149	NMOD	I-protein
T44	I-Entity	1472	1479	ankyrin	ankyrin	I-NP	NN	I-protein	149	NMOD	I-protein
T44	I-Entity	1480	1485	motif	motif	I-NP	NN	I-protein	149	NMOD	I-protein
T44	I-Entity	1486	1492	domain	domain	I-NP	NN	I-protein	142	OBJ	I-protein
O	O	1492	1493	,	,	O	,	O	149	P	O
O	O	1494	1499	which	which	B-NP	WDT	O	149	NMOD	O
O	O	1500	1508	mediates	mediate	B-VP	VBZ	O	151	SBAR	O
O	O	1509	1520	cytoplasmic	cytoplasmic	B-NP	JJ	O	154	NMOD	O
O	O	1521	1530	retention	retention	I-NP	NN	O	152	OBJ	O
O	O	1531	1533	of	of	B-PP	IN	O	154	NMOD	O
T32	B-Protein	1534	1538	RelA	RelA	B-NP	NN	B-protein	155	PMOD	B-protein
O	O	1538	1539	;	;	O	:	O	160	P	O
O	O	1540	1543	and	and	O	CC	O	160	DEP	O
O	O	1544	1545	(	(	B-LST	(	O	160	DEP	O
O	O	1545	1547	vi	vi	I-LST	LS	O	3	VMOD	O
O	O	1547	1548	)	)	O	)	O	160	DEP	O
O	O	1549	1551	as	as	B-SBAR	IN	O	160	DEP	O
O	O	1552	1560	observed	observe	B-VP	VBN	O	162	SBAR	O
O	O	1561	1565	with	with	B-PP	IN	O	163	VMOD	O
T33	B-Protein	1566	1567	I	I	B-NP	NN	B-protein	168	NMOD	B-protein
T33	I-Protein	1568	1573	kappa	kappa	I-NP	NN	I-protein	168	NMOD	I-protein
T33	I-Protein	1574	1575	B	B	I-NP	NN	I-protein	168	NMOD	I-protein
T33	I-Protein	1576	1581	alpha	alpha	I-NP	NN	I-protein	172	SUB	I-protein
O	O	1581	1582	,	,	O	,	O	172	P	O
O	O	1583	1590	nuclear	nuclear	B-NP	JJ	O	171	NMOD	O
T34	B-Protein	1591	1595	RelA	RelA	I-NP	NN	B-protein	172	SUB	B-protein
O	O	1596	1606	stimulates	stimulate	B-VP	VBZ	O	164	SBAR	O
T35	B-Protein	1607	1611	p100	p100	B-NP	NN	B-RNA	177	NMOD	B-RNA
O	O	1612	1616	mRNA	mRNA	I-NP	NN	I-RNA	177	NMOD	I-RNA
O	O	1617	1620	and	and	O	CC	O	177	NMOD	O
O	O	1621	1628	protein	protein	B-NP	NN	O	177	NMOD	O
O	O	1629	1639	expression	expression	I-NP	NN	O	172	OBJ	O
O	O	1639	1640	.	.	O	.	O	160	P	O

O	O	1641	1646	These	These	B-NP	DT	O	2	NMOD	O
O	O	1647	1655	findings	finding	I-NP	NNS	O	4	SUB	O
O	O	1656	1660	thus	thus	B-ADVP	RB	O	4	VMOD	O
O	O	1661	1667	reveal	reveal	B-VP	VBP	O	0	ROOT	O
O	O	1668	1671	the	the	B-NP	DT	O	6	NMOD	O
O	O	1672	1680	presence	presence	I-NP	NN	O	4	OBJ	O
O	O	1681	1683	of	of	B-PP	IN	O	6	NMOD	O
O	O	1684	1685	a	a	B-NP	DT	O	13	NMOD	O
O	O	1686	1692	second	second	I-NP	JJ	O	13	NMOD	O
O	O	1693	1702	inducible	inducible	I-NP	JJ	O	13	NMOD	O
O	O	1703	1716	autoregulated	autoregulated	I-NP	JJ	O	13	NMOD	O
O	O	1717	1727	inhibitory	inhibitory	I-NP	JJ	O	13	NMOD	O
O	O	1728	1735	pathway	pathway	I-NP	NN	O	7	PMOD	O
O	O	1736	1740	that	that	B-NP	WDT	O	13	NMOD	O
O	O	1741	1746	helps	help	B-VP	VBZ	O	14	SBAR	O
O	O	1747	1753	ensure	ensure	I-VP	VB	O	15	VMOD	O
O	O	1754	1757	the	the	B-NP	DT	O	21	NMOD	O
O	O	1758	1763	rapid	rapid	I-NP	JJ	O	20	AMOD	O
O	O	1764	1767	but	but	I-NP	CC	O	20	AMOD	O
O	O	1768	1777	transient	transient	I-NP	JJ	O	21	NMOD	O
O	O	1778	1784	action	action	I-NP	NN	O	16	OBJ	O
O	O	1785	1787	of	of	B-PP	IN	O	21	NMOD	O
O	O	1788	1795	nuclear	nuclear	B-NP	JJ	B-protein	27	NMOD	B-protein
T45	B-Entity	1796	1798	NF	NF	I-NP	NN	I-protein	27	NMOD	I-protein
T45	I-Entity	1798	1799	-	-	B-NP	HYPH	I-protein	27	NMOD	I-protein
T45	I-Entity	1799	1804	kappa	kappa	I-NP	NN	I-protein	27	NMOD	I-protein
T45	I-Entity	1805	1806	B	B	I-NP	NN	I-protein	22	PMOD	I-protein
O	O	1806	1807	.	.	O	.	O	4	P	O
